Search by Drug Name or NDC

    NDC 49687-0014-00 Burn Treatment .13; .5 g/100g; g/100g Details

    Burn Treatment .13; .5 g/100g; g/100g

    Burn Treatment is a TOPICAL CREAM in the HUMAN OTC DRUG category. It is labeled and distributed by CMC Group Inc.. The primary component is BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE.

    Product Information

    NDC 49687-0014
    Product ID 49687-0014_b856a95e-6be8-d0f8-e053-2a95a90af28b
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Burn Treatment
    Proprietary Name Suffix n/a
    Non-Proprietary Name BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form CREAM
    Route TOPICAL
    Active Ingredient Strength .13; .5
    Active Ingredient Units g/100g; g/100g
    Substance Name BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE
    Labeler Name CMC Group Inc.
    Pharmaceutical Class Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part333A
    Listing Certified Through 2022-12-31

    Package

    NDC 49687-0014-00 (49687001400)

    NDC Package Code 49687-0014-0
    Billing NDC 49687001400
    Package 10 POUCH in 1 KIT (49687-0014-0) / .9 g in 1 POUCH
    Marketing Start Date 2016-08-06
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 9dd56b66-48c0-4bcf-a9a8-ba2f1e11ce40 Details

    Revised: 1/2021